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Abstract 
 
Background/Aim. Low-level laser therapy (LLLT) has been 
proven to stimulate bone repair, affecting cellular prolifera-
tion, differentiation and adhesion, and has shown a potential 
to reduce the healing time following implant placement. The 
aim of this clinical study was to investigate the influence of 
postoperative LLLT osseointegration and early success of 
self-tapping implants placed into low-density bone. Meth-
ods. Following the split-mouth design, self-tapping implants 
(n = 44) were inserted in the posterior maxilla of 12 patients. 
One jaw side randomly received LLLT (test group), while the 
other side was placebo (control group). For LLLT, a 637 nm 
gallium-aluminum-arsenide (GaAlAs) laser (Medicolaser 637, 
Technoline, Belgrade, Serbia) with an output power of 40 
mW and continuous wave was used. Low-level laser treat-
ment was performed immediately after the surgery and then 
repeated every day in the following 7 days. The total irradia-
tion dose per treatment was 6.26 J/cm² per implant. The study 
outcomes were: implant stability, alkaline-phosphatase (ALP) 
activity and early implant success rate. The follow-up took 6 
weeks. Results. Irradiated implants achieved a higher stability 
compared with controls during the entire follow-up and the 
difference reached significance in the 5th postoperative 
week (paired t-test, p = 0.030). The difference in ALP activ-
ity between the groups was insignificant in any observation 
point (paired t-test, p > 0.05). The early implant success rate 
was 100%, regardless of LLLT usage. Conclusion. LLLT 
applied daily during the first postoperative week expressed 
no significant influence on the osseointegration of self-
tapping implants placed into low density bone of the poste-
rior maxilla. Placement of self-tapping macro-designed im-
plants into low density bone could be a predictable thera-
peutic procedure with a high early success rate regardless of 
LLLT usage. 
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Apstrakt 
 
Uvod/Cilj. Terapija laserom male snage (TLMS) stimuliše 
reparatorne sposobnosti kosti utičući na ćelijsku proliferaci-
ju, diferencijaciju i adheziju, i ima potencijal da skrati vreme 
zarastanja kosti nakon ugradnje implantata. Cilj ove kliničke 
studije bio je da se ispita uticaj postoperativne primene 
TLMS na oseointegraciju i rani uspeh ugradnje samourezu-
jućih implantata u kost male gustine. Metode. Prateći split-
mouth dizajn, samourezujući implantati (n = 44) ugrađeni su 
u posteriorne regije gornje vilice 12 pacijenata. Slučajnim iz-
borom, jednoj od strana vilice je dodeljena TLMS (test gru-
pa), dok je druga strana bila placebo (kontrolna grupa). Za 
TLMS korišćen je galijum-aluminijum-arsenid (GaAlAs) la-
ser (Medicolaser 637, Technoline, Beograd, Srbija) talasne 
dužine 637 nm, snage 40 mW, neprekidnog režima rada. 
Tretman laserom male snage sprovodio se neposredno po 
ugradnji, a zatim svakodnevno, tokom narednih sedam da-
na. Ukupna zračna doza po tretmanu bila je 6,26 J/cm² po 
implantatu. Praćeni su stabilnost implantata, aktivnost alkal-
ne fosfataze (ALP) i procenat rane uspešnosti implantatne 
terapije. Period praćenja bio je šest nedelja. Rezultati. Zra-
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čeni implantati imali su veću stabilnost u odnosu na kon-
trolne tokom celog perioda praćenja, a statistički značajno 
veća stabilnost bila je u petoj postoperativnoj nedelji (t-test 
za vezane uzorke, p = 0.030). Razlika u aktivnosti ALP iz-
među grupa nije bila statistički značajna ni u jednoj tački po-
smatranja (t-test za vezane uzorke, p > 0.05). Procenat rane 
uspešnosti terapije implantatima bio je 100%, bez obzira na 
primenjenu TLMS. Zaključak. Svakodnevna primena 
TLMS u prvoj postoperativnoj nedelji nije pokazala znača-
jan uticaj na oseointegraciju samourezujućih implantata u 
kost male gustine bočne regije gornje vilice. Primena im-
plantata samourezujućeg makrodizajna u kosti male gustine 
mogla bi predstavljati predvidljivu terapijsku proceduru sa 
visokim procentom rane uspešnosti, bez obzira na prime-
njenu TLMS. 
 
Ključne reči: 
implantati, stomatološki; hirurgija, oralna, procedure; 
lečenje laserom male snage; kost, regeneracija; alkalna 
fosfataza; lečenje, ishod. 
 
Introduction 
Low-level laser therapy (LLLT) has been used for more 
than 30 years in the medical field and no adverse effects 
have been reported 1. It is defined as red beam or near-
infrared laser therapies of low energy density and output 
power, with wavelengths between 500 and 1,200 nm, that do 
not increase normal tissue and body temperature 1. Its effects 
are therefore nonthermal and biostimulative. 
As LLLT affects various tissue responses such as blood 
flow, inflammation, cellular proliferation and/or differentia-
tion 2, stimulation with LLLT creates a number of environ-
mental conditions that appeared to have accelerated healing 
of bone defects in animal models and clinical investiga-
tions 2–5.  
Though the exact mechanism of these effects is not elu-
cidated yet, they are considered to be results of laser irradia-
tion on the cell membrane, mitochondria, DNA and RNA 
synthesis, collagen synthesis, neovascularization, cell prolif-
eration, and the production of ATP 6. 
In oral implantology, research has been focused on the 
potential of LLLT to reduce the healing time following im-
plant placement and to improve the potential for bone regen-
eration 2.  
Previous experimental studies reported that low-level 
laser treatment stimulated proliferation and differentiation of 
osteoblasts 7–11 as well as their bonding to titanium implant 7. 
It significantly increased alkaline phosphatase (ALP) activ-
ity, which is considered to be a marker of differentiated os-
teoblasts, in culture 8, 9, 11 and animal models 10. When ap-
plied in the early postoperative period, LLLT lead to an en-
hancement of the mechanical strenght of bone-implant inter-
face 12–14 and stimulation of bone matrix production and bone 
nodule formation 9. 
There are a number of studies suggesting that low-level 
laser treatment in the early postoperative period after implant 
placement may lead to a positive clinical effect 2. 
As low-density bone (D3 and D4 class of bone, Leck-
holm & Zarb classification 15) is usually present in the molar 
region of the upper jaw, this has proven to be the region of 
lower success rates of dental implant therapy due to lack of 
primary stability that can be obtained 16. Postoperative LLLT 
might have potential beneficial influence on dental implant 
treatment in this area, making it more predictable. 
The aim of our study was to investigate the influence of 
postoperative LLLT on osseointegration of self-tapping im-
plants placed into low density bone, by investigating and 
comparing clinical status – implant stability  with the ap-
pearance of the marker of alkaline phosphatase in the 
periimplant crevicular fluid. The second aim was to evaluate 
early success rate of implants placed into the premolar/molar 
maxillary region, regarding LLLT. 
Methods 
The study was conducted in accordance with the 1975 
Declaration of Helsinki, as revised in 2002. The protocol was 
approved by the Ethics Commitee of the Faculty of Den-
tistry, University of Belgrade (No.36/22), and the patients 
gave their written informed consent. Written patient’s con-
sent was also obtained to publish clinical photographs. 
A total of 12 patients (6 males and 6 females) seeking 
implant therapy for bilateral reconstruction in the posterior 
maxilla were recruited for this study. All the patients were 
healthy adults, age 18 or older. The patients were selected in 
accordance with the following inclusion criteria: sufficient 
bone volume to receive implants without requiring bone 
augmentation (reconstruction) procedures and no history of 
previous tooth extraction in the last six months in the se-
lected area. Exclusion criteria were: 1) systemic: pregnancy 
or lactation, systemic disease that affects osseointegration, 
anticoagulant therapy, systemic glucocorticoid therapy, his-
tory of radiotherapy in the craniofacial region within last 12 
months, smoking habit of more than 10 cigarettes per day 
and 2) local: acute infection in the mouth, uncontrolled or 
untreated periodontal disease. 
For patients' selection and treatment planning, pano-
ramic radiographs and 3D computed tomography scans were 
required, followed by clinical intraoral examination. 
Following split mouth design, a total of 44 self-tapping 
BlueSky® (Bredent, Germany) implants with diameter of 4 
mm and length of 10 mm were inserted bilaterally and simet-
rically in the posterior maxilla of the selected patients. 
Local anesthesia was induced by infiltration with 2% 
lidocaine hydrochloride and 1: 80 000 adrenaline. After cre-
stal incision and mucoperiosteal flap elevation, preparations 
of implant recipient sites were performed under cooling with 
physiological solution, according to the protocol following 
the manufacturer’s instructions (Bredent, Germany). The 
speed of 15 rpm with a torque of 35 Ncm was set for inser-
tion of all implants. The implants were allowed to heal 
transmucosally and sutures were removed after 7 days.  
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Postoperatively all the patients were prescribed amox-
icillin (1.5 g) or clindamycin (1.8 g) daily, for three days as 
well as nonsteroidal anti-inflammatory drugs for pain relief. 
The patients were also given detailed instructions with regard 
to oral hygiene. No temporary prosthesis was placed during 
the entire 6-week observation period.  
After the surgery, one of the sides of the upper jaw of 
the patients was randomly (computer-generated random 
numbers) chosen to receive low-level laser treatment (test 
group). The other side of the jaw was placebo, without any 
treatment performed and served as a control (control group).  
A 637 nm gallium-aluminum-arsenide (GaAlAs) laser 
(Medicolaser 637, Technoline, Belgrade, Serbia) with an out-
put power of 40 mW and continuous wave was used. The im-
plant on the chosen side was irradiated intraorally, orthora-
dially to the implant's longitudinal axis (Figure 1). Low-level 
laser treatment was performed immediately after the surgery 
and then repeated every day in the following 7 days. The total 
irradiation dose per treatment was 6.26 J/cm² per implant. 
 
 
Fig. 1 – Postoperative low-level laser therapy. The 
operational field was irradiated by laser probe positioned 
intraorally, at a distance of 1 cm and orthoradially to the 
implant's longitudinal axis. 
 
Evaluation of osseointegration of implants 
All assessments of the study outcomes were preformed 
in a double blind manner, since neither patients (due to pla-
cebo) or assessors (not involved in LLLT) were aware of 
treatment allocation. 
Resonance frequency analysis (RFA) was performed us-
ing the Osstell™ Mentor instrument (Integration Diagnostics, 
Göteborg, Sweden) by a trained calibrated operator who was 
unaware of which side would be irradiated. Measurements 
were recorded immediately after implant insertion and then 
postoperatively in a weekly manner during the following 6 
weeks. A standardized abutment of fixed length (Smartpeg™ 
Integration Diagnostics, Göteborg, Sweden) was inserted and 
hand-tightened into each implant. The transducer probe 
(Osstell™ Mentor Probe) was held so that the probe tip was 
aimed at the small magnet on top of the Smartpeg™ at a dis-
tance of 2–3 mm (Figure 2). It was held still until the instru-
ment beeped and displayed the implant stability quotient (ISQ) 
value. Each measurement was repeated until the same value 
was recorded twice, which was accepted as the authentic val-
ue. For the post-surgical stability measurements, abutments 
were removed from the implants.  
 
 
Fig. 2 – Implant stability measurement by means of  
resonance frequency analysis. The hand-held probe 
stimulates magnetically the transducer attached to the 
implant. The degree of implant stability is shown on the 
display as implant stability quotient value. 
 
Evaluation of bone remodelation intensity and 
osteoblast differentiation 
Peri-implant crevicular fluid (PICF) sampling was per-
formed on the postoperative day 7, 14, 21 and 28.  
To avoid mechanical irritation, blood contamination or 
stimulation of the PICF, PICF samples were collected before 
the clinical measurements. Briefly, following the isolation of 
the sampling area with sterile cotton rolls, supragingival 
plaque was removed and the sampling site was gently air dried 
to reduce any contamination with plaque and saliva. Extreme 
care was taken to minimize the level of mechanical irritation 
during PICF sampling as this is known to affect the actual flu-
id volume in a given site. Standardized sterile paper strip (Pe-
riopaper® N° 593525, Oraflow Inc, Amityville NY) was 
placed at the entrance of peri-implant sulcus and pushed until 
minimal resistance was felt (Figure 3). Sampling time was 
 
 
Fig. 3 – Peri-implant crevicular fluid collection. After the 
isolation of implant sites with cotton rolls, standardized pa-
per strips were inserted into the sulci until a slight resis-
tance was felt. 
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standardized as 60 s. Samples with visible blood contamina-
tions were discarded. Paperstrips with PICF from single im-
plants were immediately used for ALP activity determination.  
A quantity of 20 µl of distilled water was added to each 
sample. The tubes were vigorously shaken for 1 min and 
then centrifuged at 2,000 g for 5 min with the strips kept at 
the collar of the tube in order to completely elute PICF com-
ponents.  
ALP activity was assayed spectrophotometrically with 
spectrophotometer at 405 nm (Secomam Basic, France). The 
principle of method is coloured reaction in which ALP hy-
drolyses p-nitrophenyl phosphate in the presence of magne-
sium ions to yellow product p-nitrophenol and inorganic 
phosphate. The reaction of 10 µl of the sample with 500 µl 
of the working reagent is at 37 °C, and the rate of increase in 
absorbance is read after 1 min, then in 1 min intervals and fi-
nally recorded after 4 minutes at 405 nm. ALP activity is ex-
pressed in U, where U (international unit) represents the 
amount of enzyme that catalyses release of 1 µmol of p-
nitrophenol per min at 37 °C. The final results were reported 
as total ALP activity (U/sample). 
Evaluation of early implant success 
Early implant success was evaluated after the sixth 
postoperative week using the following criteria proposed by 
Buser et al. 17: 1) the absence of recurring peri-implant infec-
tion with suppuration; 2) the absence of persistent subjective 
complaints such as pain, foreign body sensation, and/or 
dysesthesia, 3) the absence of a continuous radiolucency 
around the implant and 4) the absence of any detectable im-
plant mobility. 
Possible adverse events related to LLLT were also re-
corded during a 6-week follow-up.  
Statistical analysis was performed using the SPSS® 17.0 
software (SPSS Inc., Chicago, IL, USA). Implants were used 
as units of analysis. ISQ and ALP activity data were reported 
using measures of central tendency (mean, median) and varia-
tion (standard deviation, min, max, 95% confidence interval 
(CI). One-sample Kolmogorov–Smirnov test was used to as-
sess the normality of data distribution. Repeated measures 
analysis of variance was performed to analyze changes of ISQ, 
as well as ALP activity data, during the observation period and 
was followed by post hoc least significant difference test to de-
termine differences within groups between particular observa-
tion points. The statistical significance of differences in the 
observed parameters (ISQ and  ALP activity) between the 
groups in each observation point was analyzed using paired 
samples t-test since data from strictly symmetrical positions of 
the implants were compared (split-mouth design). The statisti-
cal significance of all tests was defined as p < 0.05. 
Results 
Twelve eligible patients were enrolled in the study. They 
received a total of 44 implants. Since all 4 implants of one 
male patient aged 68 inserted bilaterally into the regions of the 
first and the second maxillary molars failed to achieve primary 
stability sufficient for the one- stage surgery approach, they 
were covered, not irradiated and excluded from the study. 
Eleven remaining patients of both genders (5 females and 6 
males), mean age 61.28 years (55 to 75) enrolled in this study 
completed the study protocol. They received a total of 40 im-
plants bilaterally inserted into premolar and/or molar maxillary 
regions, with 20 implants randomly and symmetrically attrib-
uted to each of the two groups, irradiated (test) or non-
irradiated (control) group that were included in the analyses. A 
total follow-up period per patient was 6 weeks.  
Resonance frequency analysis 
Within the test group significant changes were recorded 
during a 6-week follow-up (p = 0.016) (Table 1, Figure 4). 
The maximum stability was achieved at baseline and after-
wards significantly declined in the 2nd, 3rd and 4th week (p 
= 0.029; p = 0.007; p = 0.008; respectively) with the minimal 
recorded value in the 4th week. In the 5th week it started to 
rise insignificantly, but fell again in the 6th week, in both ob-
 
Table 1 
Descriptive statistics for implant stability measurements by means of resonance frequency analysis in test (irradiated) and 
control (non-irradiated) implants at baseline and during six postoperative weeks 
Time Side ґ ± SD Med Min Max 95% CI 
test 76.00 ± 3.52 75.5 70 82 74.25–77.75 
Baseline control 72.89 ± 7.15 74.5 56 80 69.33–76.45 
test 74.88 ± 3.40 75 70 82 73.06–76.69 
1st week control 74.69 ± 4.80 74.5 67 84 72.13–77.24 
test 74.22 ± 3.93 74 68 81 72.27–76.18 
2nd week control 72.56 ± 5.67 72.5 61 80 69.74–75.37 
test 72.67 ± 3.65 73 61 77 70.85–74.48 
3rd week control 70.44 ± 6.16 70 55 80 67.38–73.51 
test 72.50 ± 4.18 73 60 77 70.42–74.58 
4th week control 69.22 ± 9.09 70 39 79 64.70–73.74 
test 72.94 ± 3.92 73.5 63 79 71.00–74.89 
5th week control 69.83 ± 7.03 71.5 48 78 66.34–73.33 
test 72.67 ± 3.69 73.5 63 78 70.83–74.50 6th week control 70.61 ± 7.20 72 52 79 67.03–74.19 
The results are presented as implant stability quotient values. 
CI – confindence interval. 
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servation points still being significantly lower than the base-
line stability (p = 0.017; p = 0.005; respectively). The differ-
ences in ISQ values between both consecutive weeks within 
the test group were not significant (p > 0.05). 
 
 
Fig. 4 – Effect of low-level laser therapy on implant stability 
measured by resonance frequency analysis. 
 
In the control group significant changes in implant sta-
bility over time were revealed (p = 0.023) (Table 1, Figure 
4). The maximum implant stability was achieved in the 1st 
week, and afterwards significantly decreased in the consecu-
tive 2nd and 3rd week (p = 0.047; p = 0.044; respectively). 
An insignificant decrease continued in the 4th week (p = 
0.234), when the minimum value was recorded and was sig-
nificantly lower than baseline stability (p = 0.039). After-
wards it started to rise insignificantly during the 5th and 6th 
consecutive weeks (p = 0.401; p = 0.110; respectively) with 
ISQ values recorded in the 5th week being significantly low-
er compared to baseline stability (p = 0.029) whereas stabil-
ity recorded in the 6th week was insignificantly different 
compared to baseline (p = 0.074).  
Between group comparative analysis revealed higher 
ISQ values in the test group compared to the controls dur-
ing the entire 6-week observation period with the differ-
ence  being statistically significant in the 5th week (p = 
0.030) (Table 2). The highest implant stability was re-
corded at baseline, in the test group. Both groups showed 
the "stability dip" (with the lowest ISQ values) in the 4th 
week, with the minimal recorded ISQ value in the control 
group (Figure 4). 
Alkaline-phosphatase activity   
Within the test group, statistically significant changes 
of ALP activity were observed during the 4-week observa-
tion period (p < 0.0005) (Table 3, Figure 5). The highest 
ALP activity was recorded in the 1st week and afterwards 
significantly decreased in the 2nd week (p ≤ 0.005). An in-
significant decrease continued from the 2nd week till the 3rd 
week (p = 0.175) followed by an insignificant increase re-
corded in the 4th week (p = 1.000). The ALP activity value 
in each observation point (2nd, 3rd and 4th week) was sig-
nificantly lower than in the 1st postoperative week (p ≤ 
0.0005; p ≤ 0.0005; p = 0.010; respectively). 
 
 
Fig. 5 – Effect of low-level laser therapy on alkaline 
phosphatase (ALP) activity in peri-implant crevicular fluid, 
 measured spectrophotometrically during a 4-week 
observation period. 
Table 2 
Differences in implant stability between irradiated (test ) and non-irradiated (control) implants 
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Implant stability quotient 
(ґ ± SD) Time 
test control 95% CI for MD 
p 
Baseline 76.00 ± 3.52 72.89 ± 7.15 -0.78177  to 7.00399 0.110 
1st week 74.88 ± 3.40 74.69 ± 4.80 -3.45378 to 3.82878 0.914 
2nd week 74.22 ± 3.93 72.56 ± 5.67  -1.73616 to 5.06950 0.316 
3rd week 72.67 ± 3.65 70.44 ± 6.16 -0.88360 to 5.32805 0.150 
4th week 72.50 ± 4.18 69.22 ± 9.09 -0.72534 to 7.28089 0.102 
5th week 72.94 ± 3.92 69.83 ± 7.03  0.34554 to 5.87668 0.030* 
6th week 72.67 ± 3.69 70.61 ± 7.20 -0.60045 to 4.71157 0.121 
MD – mean difference; *p values (paired samples t-test) – statistically significant;  
CI – confidence interval. 
Table 3 
Descriptive statistics for alkaline phosphatase activity assayed spectrophotometrically in test (irradiated)  
and control (non-irradiated) implants during four week observation period. 
Time Side Mean Med Min Max 95% CI 
test 21.53 ± 6.65 24.47 9.87 30.13 18.22–24.84 
1st week control 18.16 ± 5.11 17.92 9.73 26.87 15.62–20.71 
test 11.26 ± 4.64 10.40 4.48 17.77 8.95–13.57 
2nd week control 10.39 ± 4.05 9.35 4.68 17.17 8.23–12.55 
test 9.36 ± 4.23 8.82 4.20 19.32 7.25–11.46 
3rd week control 10.22 ± 4.26 8.50 3.08 17.92 8.03–12.41 
test 11.96 ± 8.34 8.89 5.46 39.92 7.81–16.10 4th week control 8.45 ± 3.46 7.47 3.05 18.97 6.73–10.17 
The results are presented as U/sample, where U (international unit) represents the amount of enzyme that catalyses release of 1 µmol  
of p-nitrophenol per min at 37 °C; CI –confidence interval. 
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In the control group ALP activity values significantly 
changed during the 4-week follow-up (p < 0.0005) (Table 3, 
Figure 5). The maximum ALP activity was recorded in the 
1st postoperative week and then continuously declined until 
the end of the 4th week. This decline was significant in the 
2nd, 3rd and 4th week (p = 0.006; p = 0.003; p < 0.0005; re-
spectively) in comparison with the 1st one. The decrease in 
ALP activity between the 1st and the 2nd week was statisti-
cally significant (p = 0.006) whereas no significant differ-
ence in ALP activity was observed between the 2nd and 3rd 
week (p = 1.000), neither between the 3rd and 4th postopera-
tive week (p = 0.743). 
The mean ALP values were higher in the test group 
during a 4-week follow-up, except in the 3rd postoperative 
week, but the difference between the groups was not statisti-
cally significant at any time of observation (Table 4). The 
pattern of ALP activity changes over time was different in 
the test and control groups (Figure 5). After the initial de-
cline of ALP activity in the test group an increase in the 4th 
week was observed reaching values similar to those of the 
2nd week (p = 1.000), whereas in the control group a con-
tinuous decrease was recorded. 
Early implant success 
The early implant success rate after the first six weeks 
(prior to implant placement) was 100%, regardless of LLLT 
usage.  No adverse event was recorded during the follow-up. 
Discussion 
Osseointegration is an essential prerequisite for the 
dental implants' long-term prognosis. Therefore, chemical, 
biological and biophysical adjunctive therapies to improve 
and accelarate healing at bone-implant interface have been 
widely investigated 18. This randomized, double blind, 
split-mouth clinical study was focused on the effect of 
postoperative LLLT using a 637 nm GaAlAs laser with an 
output power of 40 mW and total irradiation dose per 
treatment of 6.26 J/cm² per implant, on osseointegration of 
self-tapping implants placed into posterior maxilla. Our in-
tention was to explore this effect on bone healing after den-
tal implant placement in the maxillary premolar and/or mo-
lar region, being the area of the least predictible success of 
implant therapy 16, where the use of LLLT might be of ma-
jor clinical relevance. The results of our study suggest that 
LLLT did not significantly affect the osseointegration of 
self-tapping implants placed into low density bone of pos-
terior maxilla.  
A 637 nm GaAlAs laser has been chosen due to its ben-
eficial effects on bone regeneration reported in animal 3 and 
clinical studies 4. LLLT has been found to increase os-
teoblastic proliferation, collagen deposition, and bone neo-
formation in the irradiated comparing to non-irradiated 
bone 3, 9. Studies using animal models and human osteoblast-
like cells cultures, demonstrated that the use of low-level la-
ser after titanium implant insertion promoted osseointegra-
tion due to rapid bone turnover 7, 12 and seemed to accelerate 
active bone replacement without causing tissue or implant 
damage 7. Histomorphometric evaluation in animal models 
revealed more bone-implant contact in the irradiated groups 
as compared to the controls at 3 and 6 19 and 16 weeks post-
operatively 20. These results suggest that LLLT may stimu-
late bone repair, affecting cellular proliferation, differentia-
tion and adhesion 7–14, 19, 20.  
 
Table 4 
 Differences in alkaline phosphatase (ALP) activity between irradiated (test)  
and non-irradiated (control) implants 
ALP (ґ ± SD) Time Test Control 95% CI of MD p 
1st week 21.53 ± 6.65 18.16 ± 5.11 -0.50252 to 7.24085 0.084 
2nd week 11.26 ± 4.64 10.39 ± 4.05 -0.26683 to 3.42371 0.088 
3rd week 9.36 ± 4.23 10.22 ± 4.26 -2.77642 to 1.61913 0.584 
4th week 11.9 ± 8.34 8.45 ± 3.46 -0.85890 to 7.87234 0.108 
ALP activity is presented in U/L; MD – mean difference; p- values (paired samples t-test) 
CI – confidence interval. 
 
In this study osseointegration was evaluated through its 
two indicators – secondary implant stability measured by 
means of RFA and ALP activity assayed spectrophotometri-
cally. Secondary implant stability is a clinical reflection of 
cellular events in peri-implant healing department and there-
fore indicates the rate and extent of osseointegration 21. We 
used RFA as a non-invasive method that has proved to be a 
reliable tool to assess implant stability, determine different 
healing phases of dental implants  and predict success of im-
plant treatment 21. Longitudinal ISQ values in both groups 
followed the usual pattern of changes with "stability dip" in 
the 4th postoperative week that reflected bone remodeling 
process when primary spongiosa was being replaced with 
lamellar and/or parallel-fibered bone 16, 22. The trend of 
higher ISQ values recorded in the test group compared to 
controls during the entire 6-week period of observation, 
reached a significant difference in the 5th postoperative 
week. This result might suggest biomodulatory effect of 
LLLT that increases cellular activity and bone apposition but 
still not clinically significant to provide an earlier and better 
anchorage of implants. Statistically significant regeneration 
of bone tissue around irradiated implants was recorded in an 
intermediate period, which was in agreement with literature 
data 13, 23. It has been shown that although LLLT is capable 
to increase the number of osteogenic cells in the very initial 
stage of healing, its effect on implant stabilization in this 
stage is still insignificant 13, 23. Conversely, previous reports 
of animal studies reported that postoperative LLLT improved 
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biomechanical characteristics of bone-implant interface 12–14. 
The authors agreed that single 14 or multisession 12, 13 LLLT 
was beneficial to improve bone-implant interface strength, 
resulting in higher values of removal torque required to de-
tach bone and implant in sites previously submitted to irra-
diation in comparison to non-irradiated sites 13, 14.  
The only clinical study that investigated the stability of 
oral implants after LLLT was the study of Garcià-Morales et 
al. 24. Under the conditions of their study, no evidence was 
found of any effect of LLLT on the stability of implants 
when measured by RFA. The authors remarked that potential 
beneficial effect of LLLT was perhaps masked by high initial 
stability attained in the posterior mandible region 24. With 
regard to different irradiation protocol used in a Garcià-
Morales study 24  (infrared laser with seven irradiations re-
peated every 48 h for the first 14 days), as well as different 
implantation sites, comparison with our results is difficult. 
In our study, during the whole 6-week observation pe-
riod in both irradiated and non-irradiated implants, implant 
stability rates were high (≥ 69 ISQ), which is interesting, 
since the implantation site was the posterior maxilla. These 
results could probably be explained by the self-tapping im-
plant design as has been previously demonstrated by a recent 
randomized clinical trial 25. Exceptionally, four implants of 
one male patient aged 68 inserted bilaterally into the regions 
of the first and the second maxillary molars failed to achieve 
primary stability sufficient for one stage surgery approach. 
Although the cause of poor implant stability remains unclear, 
the fact that all the implants were placed to the same patient 
indicates the probable systemic factor despite the incon-
spicuous medical history. Regardless of the possibility of 
LLLT to promote the osseointegration of implants with poor 
primary stability demonstrated in animal model 26 we decided 
to cover them and exclude from the study due to concerns 
that weekly RFA measurements during early healing might 
damage weak bone-implant interface resulting in implant 
failure. 
We compared clinical status of the implant – its stability, 
with the appearance of the marker of ALP in the peri-implant 
crevicular fluid. ALP is considered to be a marker of differen-
tiated osteoblasts and their activity, as early progenitor cells do 
not express ALP activity but differentiate through a defined 
number of cell divisions to express ultimately a mature os-
teoblast phenotype that is capable of bone formation 27. Our 
results revealed significant changes in ALP activity longitudi-
nally in time, i.e. during the 4-week observation period, within 
both groups. The significantly enhanced ALP activity in the 
early stage of bone tissue healing (first postoperative week) 
was found in both irradiated and non-irradiated implants. As 
new bone formation starts as early as 1 week after implant 
placement when the primary bone contacts are supplemented 
by newly formed secondary bone contacts 28, this result may 
indicate an intensive osteoblastic activity around implants, i.e. 
bone formation. On the other hand, a subsequent decrease of 
ALP activity from the second week and onwards, would there-
fore be the result of greater presence of differentiated cells (os-
teocytes) at the implant-bone interface. However, this is un-
likely the case, as this is too early for the bone deposition pro-
cess to decline. Apart from that released from osteoblasts dur-
ing bone remodeling, ALP found in PICF can also derive from 
polymorphonuclear cells during inflamation 29 and periodontal 
fibroblasts during periodontal regeneration 30. Increased ALP 
activity in the first postoperative week is therefore more likely 
the result of inflammation that occurs as a physiological re-
sponse to operation trauma, and which presents the first phase 
of osseointegrating process.  
Although our results showed no statisticaly significant 
difference in ALP activity between the test and control group 
in all observation points, the pattern of ALP activity changes 
over time was different. In contrast to the control group 
where continuous decrease of ALP activity was recorded, in 
the test group after the initial decline, an increase was ob-
served in the 4th week. The increase in ALP activity in the 
laser group might be interpreted as an indication of enhanced 
osteoblast activity and therefore, improved bone neoforma-
tion and mineralization. This biochemical result was sup-
ported by our clinical finding from the 5th observation week 
when a significantly higher stability was recorded for irradi-
ated implants compared to controls, suggesting beneficial ef-
fect of LLLT on osseointegration.    
Previous in vitro 8, 9, 11 and animal 10 studies reported on 
enhancements in the ALP activity as well as matrix forma-
tion after LLLT, which the authors considered as an indica-
tion of increased osteoblastic activity after LLLT.   
Generalisation of our results might be affected by bone 
density, implant macro design, as well as irradiation protocol 
we used. In the literature, there is no consensus regarding 
LLLT protocol. The ideal wave length, energy density and 
irradiation protocol are perhaps yet to be determined. Fur-
thermore, we have used self-tapping implant macro design 
since it has been recommended for low density bone of pos-
terior maxilla in order to achieve sufficient implant stabil-
ity 25. However, non self-tapping implants are not so effec-
tive in providing good primary stability into spongy bone 
and more pronounced effect of LLLT on the healing of such 
implants could be expected since the effect of LLLT in our 
study might be masked by self-tapping design.  
Conclusion 
Low-level-laser therapy applied daily during the first 
postoperative week using a 637 nm gallium-aluminum-
arsenide (GaAlAs) laser with an output power of 40 mW and 
total irradiation dose per treatment of 6.26 J/cm² per implant 
expressed no significant influence on the osseointegration of 
self-tapping implants placed into low density bone of poste-
rior maxilla. Placement of self-tapping macro-designed im-
plants into low density bone could be predictable therapeutic 
procedure with a high early success rate regardless the low-
level laser therapy use.  
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